The Impact Of Art On Wellbeing In Autoimmune Disease PDF Print E-mail
Tuesday, 25 October 2011 09:11
taken from http://www.flickr.com/photos/georgiap/2230846846/ via creative commonsAn innovative Newcastle research project is measuring the impact of creating art on the symptoms and overall wellbeing of people living with an autoimmune illness.

A team at the University of Newcastle, in conjunction with the Autoimmune Resource and Research Centre at John Hunter Hospital, is working with participants with a range of autoimmune illnesses including Lupus, Scleroderma, Rheumatoid Arthritis and Sjögren's syndrome. Dr Kathryn Grushka from the University said the team was monitoring improvements to participants’ sense of wellbeing and measureable indicators of health, particularly levels of stress.

“Stress is a major flare factor for autoimmune illnesses. We are testing levels of the stress hormone cortisol by taking saliva samples before and after artmaking workshops,” Dr Grushka said.

Participants’ quality of life and functionality is being measured by reviewing digital and written diaries and through standard health assessments, such as testing mobility, blood pressure and heart rate.

The study consists of artists, non-artists and those without an autoimmune illness, with all participants asked to produce artworks based on personal experiences. The results are due to be published in early 2012.

Work created through the project will be displayed in the halls of John Hunter Hospital from Tuesday 4 October, Lupus awareness month, until January 2012 as part of Hunter New England Health’s ‘Arts for Health Program’.

 
More articles :

» Natural Alternatives for Dealing With Scleroderma

In a recent article, it was noted that conventional medicine attempts to treat the symptoms of with immunosuppressant drugs, NSAIDS and , but has no cure and little advice for prevention. It was noted however, that the world of natural healing has...

» Treatment for Pulmonary Arterial Hypertension Cleared

has recently reported in its that the FDA has cleared Tyvaso (treprostinil) Inhalation Solution for the treatment of pulmonary arterial hypertension (PAH). Developed by United Therapeutics Corp., of Silver Spring, Md., treprostinil is indicated to...

» Autoimmune Disease Symptoms To Look Out For

We have understood for  a long time that the detection and subsequent diagnoses of autoimmune diseases are difficult. However, there are key rheumatic and physical indicators such as joint pain and fatigue, fevers, increasing skin conditions,...

» Study Suggests Link Between Scleroderma, Cancer in Certain Patients

Patients with a certain type of may get cancer and scleroderma simultaneously, Johns Hopkins researchers have found, suggesting that in some diseases, autoimmunity and cancer may be linked.These findings could lead researchers closer to discovering...

» ArGentis Seeks More Funding After Obtaining Patent for ARG201 Therapy

ArGentis Pharmaceuticals LLC has received a patent for its scleroderma therapy while finalizing plans for a Phase IIb trial for the treatment known as ARG201.The patent comes nearly two years after it was developed by University of Tennessee Health...

» Coping with Autoimmune Diseases from a Patient’s Perspective

Offering the last presentation of the Caribbean Autoimmune Diseases Summit, Mrs. Virginia Ladd shared some great insight and tips for coping with your autoimmune disease, however from a patient’s perspective.She started off by noting as patients,...